Article
HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction.
Science translational medicine - 8 Jan 2020
Wallner Markus, Eaton Deborah M, Berretta Remus M, Liesinger Laura, Schittmayer Matthias, Gindlhuber Juergen, Wu Jichuan, Jeong Mark Y, Lin Ying H, Borghetti Giulia, Baker Sandy T, Zhao Huaqing, Pfleger Jessica, Blass Sandra, Rainer Peter P, von Lewinski Dirk, Bugger Heiko, Mohsin Sadia, Graier Wolfgang F, Zirlik Andreas, McKinsey Timothy A, Birner-Gruenberger Ruth, Wolfson Marla R, Houser Steven R
Abstract excerpt
Heart failure with preserved ejection fraction (HFpEF) is a major health problem without effective therapies. This study assessed the effects of histone deacetylase (HDAC) inhibition on cardiopulmonary structure, function, and metabolism in a large mammalian model of pressure overload recapitulating features of diastolic dysfunction common to human HFpEF. Male domestic short-hair felines (n = 31, aged 2 months)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
